Fundz

Kivu Bioscience Appoints Sophia Randolph as Chief Medical Officer

PRIVATEOct 27, 2025

Position

Chief Medical Officer

Company

Kivu Bioscience

Sophia Randolph
srandolp@kivubioscience.com
San FranciscoBiotechnologyHealth Care

Description

Kivu Bioscience has announced the appointment of Sophia Randolph, M.D., Ph.D., as Chief Medical Officer. Dr. Randolph brings over 20 years of experience in oncology drug development and will lead the company's clinical development efforts.

Quick answer

Kivu Bioscience Appoints Sophia Randolph as Chief Medical Officer (October 27, 2025). Kivu Bioscience is based in San Francisco, California, United States.

Who is the new Chief Medical Officer at Kivu Bioscience?
Kivu Bioscience named Sophia Randolph Chief Medical Officer, announced October 27, 2025.
What did Kivu Bioscience announce on October 27, 2025?
Kivu Bioscience has announced the appointment of Sophia Randolph, M.D., Ph.D., as Chief Medical Officer. Dr. Randolph brings over 20 years of experience in oncology drug development and will lead the company's clinical development efforts.
What does Kivu Bioscience do?
Kivu Bioscience is pioneering next-generation antibody-drug conjugates (ADCs) in oncology.
Where is Kivu Bioscience based?
Kivu Bioscience is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Evaxion (October 27, 2025), Organon (October 27, 2025), FDC Limited (October 27, 2025) and Pulmonx (October 27, 2025) also announced leadership changes within 45 days of Kivu Bioscience.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kivu Bioscience, and when

A new leader at Kivu Bioscience brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kivu Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kivu Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kivu Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kivu Bioscience

Location

San Francisco, California, United States

About

Kivu Bioscience is pioneering next-generation antibody-drug conjugates (ADCs) in oncology. The company’s proprietary linker-payload technology delivers enhanced safety and efficacy, minimizing off-target effects to improve patient outcomes. Kivu is advancing its first two lead candidates to clinical trials expected to begin in 2025.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kivu Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mohit
Likely contact at this company
••••••••@••••••••

See Mohit's verified email →

Ann
Likely contact at this company
••••••••@••••••••

See Ann's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kivu Bioscience's next move

Learn about Strategic plan

Kivu Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.